Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Illumina, PacBio Terminate Merger Agreement

    Jan 2, 2020, 16:55 PM by Michael Croft

    Bio-IT World | Illumina and Pacific Biosciences of California today announced that they have mutually agreed to terminate their merger agreement. In accordance with the merger agreement, Illumina will pay Pacific Biosciences a termination fee of $98 million.

    Full story
  • 2020 Bio-IT Predictions: Digital Transformation Creates Opportunity and Obstacles

    Jan 2, 2020, 10:40 AM by Michael Croft

    Bio-IT World Contributed Commentary | They say change is good, but it’s best if you have the ability to adapt. That’s certainly the case in the IT space, where digital transformation continues to drive rapid advancement across virtually every industry, and certainly in the life sciences. Here are some predictions and potential challenges to consider heading into next year.

    Full story
  • Improved data analysis with new Qlucore Omics Explorer V3.6

    Jan 2, 2020, 05:48 AM by Michael Croft
    GUILDFORD, UNITED KINGDOM - Jan 2, 2020 - Qlucore Omics Explorer (QOE) supports the user with fast, simple and visual analysis of measured data from a wide range of sources and instruments to maximize the output of the analysis
    Full story
  • BOC Sciences Launches Peptide Bioconjugation Service for Chemical Research, Diagnostics, and Therapeutic Industry

    Jan 1, 2020, 23:00 PM by Michael Croft
    SHIRLEY, NY, UNITED STATES - Jan 2, 2020 - Earlier this month, BOC Sciences announced to launch its peptide bioconjugation service for researchers involved with medicinal chemistry, diagnostics and therapeutic study
    Full story
  • Creative Peptides Launches synthetic peptide APIs for Drug Discovery and Development

    Jan 1, 2020, 22:56 PM by Michael Croft
    LONG ISLAND CITY, NY, UNITED STATES - Jan 2, 2020 - Earlier this month, Creative Peptides, one of the world’s leading peptide experts, announced to launch its synthetic peptide APIs for both researchers and manufacturers who are involved in the field of drug discovery and development
    Full story
  • MDI Biological Laboratory to Expand Innovative Data Literacy Program

    Dec 31, 2019, 10:57 AM by Michael Croft
    BAR HARBOR, ME, UNITED STATES - Dec 31, 2019 - The MDI Biological Laboratory has announced that it is expanding its innovative SEPA (Science Education Partnership Award) program, which aims to improve secondary school education in data literacy while addressing the public health threat posed by arsenic in well water
    Full story
  • X4 Pharmaceuticals Initiates Phase 1b Clinical Trial of Mavorixafor in Combination with Ibrutinib for the Treatment of Waldenström’s Macroglobulinemia (WM)

    Dec 30, 2019, 08:55 AM by Michael Croft
    CAMBRIDGE, MA, UNITED STATES - Dec 30, 2019 - X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of rare diseases, today announced the initiation of a Phase 1b clinical trial of mavorixafor (X4P-001) in combination with ibrutinib (Imbruvica®) for the treatment of Waldenström’s macroglobulinemia (WM), a rare form of non-Hodgkin’s lymphoma
    Full story
  • Creative Diagnostics Launches Hepatitis B Virus Surface Antigen Mutants for Bio-research

    Dec 29, 2019, 03:30 AM by Michael Croft
    SHIRLEY, NY - Dec 31, 2019 - As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics recently announced the launch of Hepatitis B Virus Surface Antigen Mutants manufacture platform using Yeast expression system
    Full story
  • Caris, GenScript, Fuzionaire, and More: News From December 2019

    Dec 23, 2019, 09:10 AM by Michael Croft
    Bio-IT World | December featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Caris, GenScript, Fuzionaire, and more.
    Full story
  • A Digital Transformation at the City of Hope

    Dec 19, 2019, 09:05 AM by Michael Croft

    Bio-IT World | City of Hope National Medical Center’s Chief Digital Officer discusses his role at City of Hope, the changing point-of-care landscape, and future digital transformations for the industry.

    Full story
  • Everest Medicines Announces Approval of Nefecon’s Clinical Trial Application by the China National Medical Products Administration

    Dec 18, 2019, 16:29 PM by Michael Croft
    NEW YORK, NY - Dec 18, 2019 - Shanghai, China – December 18, 2019 – Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Greater China and other parts of Asia, today announced it has received Clinical Trial Application  (CTA) approval from the China National Medical Products Administration to conduct clinical trials for Nefecon in China
    Full story
  • A Regulatory View of Personalized Therapeutics

    Dec 18, 2019, 09:10 AM by Michael Croft

    Bio-IT World | The FDA’s Director of the Center for Biologics Evaluation and Research discusses the obstacles in developing gene therapies, emerging developments in the field, and the regulatory landscape surrounding personalized therapeutics.

    Full story
  • KCR adopts Veeva Vault Clinical Suite

    Dec 17, 2019, 15:44 PM by Michael Croft
    BOSTON - Dec 17, 2019 - KCR adopts Veeva Vault Clinical SuiteThe robust cloud platform will allow enhanced integration of trial management and documentation services through these new CTMS and eTMF solutions
    Full story
  • Microway Helps Enable Next-Level Research and Education at Oregon State University

    Dec 17, 2019, 13:31 PM by Michael Croft
    PLYMOUTH, MA, UNITED STATES - Dec 17, 2019 - Microway, a leading provider of computational clusters, servers, and workstations for AI and HPC applications, announces it has provided Oregon State University with six NVIDIA® DGX-2™ supercomputer systems, deployment services, and bringup expertise
    Full story
  • Accumen Launches Healthcare Performance Publication

    Dec 17, 2019, 11:26 AM by Michael Croft
    PHOENIX, AZ - Dec 16, 2019 - Accumen Inc., the leader in healthcare performance, has launched the Healthcare Performance Insider, a monthly publication and website, providing operational, clinical and data insights from across the healthcare industry
    Full story
  • Signant Health Appoints Paul Drake as Chief Compliance and Security Officer

    Dec 17, 2019, 09:03 AM by Michael Croft
    PHILADELPHIA, PA - Dec 17, 2019 - Signant Health, announced today that it has appointed Paul Drake, PhD, MSc, as Chief Compliance and Security Officer
    Full story
  • GoZone WiFi and Safari Events Deliver Connected Shopping Experience at American Dream Megamall

    Dec 17, 2019, 08:40 AM by Michael Croft
    ST. PETERSBURG, FL, UNITED STATES - Dec 17, 2019 - GoZone WiFi (GoZone), the leading North American venue intelligence company, in partnership with Safari Event Services (Safari), today announced the deployment of their WiFi analytics and marketing solutions at the American Dream retail complex in East Rutherford, New Jersey
    Full story
  • MR Solutions participates in the first nanomedicine joint annual meeting in Dijon

    Dec 17, 2019, 06:16 AM by Michael Croft
    GUILDFORD, UNITED KINGDOM - Dec 17, 2019 - UK based MR Solutions presented a simultaneous 7T PET/MRI preclinical imaging system optimized for nanoparticle imaging to the first joint annual congress of the French Nanomedicine Society (SFNano), and the French national Competency Cluster in Nanoscience C’Nano which was held in Dijon in early December
    Full story
  • ZEISS wins R&D 100 Award for Superresolution Microscope

    Dec 16, 2019, 14:03 PM by Michael Croft
    BOSTON, MA, UNITED STATES - Dec 3, 2019 - ZEISS is among the winners of the prestigious R&D 100 Awards 2019, with judges from R&D Magazine selecting ZEISS Elyra 7 with Lattice SIM for superresolution microscopy as an award recipient in the “Analytical/Test” category
    Full story
  • BioIVT Announces the Launch of its Next-generation Sequencing Service

    Dec 16, 2019, 11:20 AM by Michael Croft

    Bio-IT World News Brief | BioIVT today launched its Next-generation Sequencing (NGS) Service, which combines the company’s expertise in human tissue procurement, specimen selection, sample preparation and project management with its in-house NGS capabilities.

    Full story
  • «
  • 211
  • 212
  • 213
  • 214
  • 215
  • 216
  • 217 (current)
  • 218
  • 219
  • 220
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy